Top Cities for Hyperparathyroidism Clinical Trials
Hyperparathyroidism clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Hyperparathyroidism
Hyperparathyroidism occurs when the parathyroid glands produce too much parathyroid hormone, leading to elevated blood calcium levels. It can cause kidney stones, bone loss, and other complications. Treatment may include surgery to remove the overactive parathyroid gland.
Clinical trials are advancing new treatments for hyperparathyroidism. Currently, 1 studies are recruiting a combined 56 participants across the United States. Research is being conducted by 1 organizations including Amgen.
2026 Hyperparathyroidism Research Landscape
As of March 2026, the hyperparathyroidism clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 56 participants, with an average enrollment target of 56 per study.
Research is being led by 1 organization, including Amgen.
Geographically, hyperparathyroidism trials are most concentrated in Los Angeles, California (1 trial); Aurora, Colorado (1 trial); Kansas City, Missouri (1 trial); New York, New York (1 trial); Cincinnati, Ohio (1 trial) and 5 other cities.
Featured Hyperparathyroidism Studies
Highlighted recruiting studies for hyperparathyroidism, selected by enrollment size and research scope.
A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
Frequently Asked Questions About Hyperparathyroidism Clinical Trials
Are there hyperparathyroidism clinical trials near me?
Yes, there are 1 hyperparathyroidism clinical trials currently recruiting across 10+ cities in the United States, including Los Angeles, California; Aurora, Colorado; Kansas City, Missouri. Browse the studies above to find one at a location convenient for you.
How do I join a hyperparathyroidism clinical trial?
To join a hyperparathyroidism clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are hyperparathyroidism clinical trials free?
Yes, participation in hyperparathyroidism clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of hyperparathyroidism treatments are being studied?
Current hyperparathyroidism clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in hyperparathyroidism clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov